PK
VIVO

Pflug Koory’s Meridian Bioscience Inc VIVO Stock Holding History

Pflug Koory’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-250
Closed -$2K – 414
2019
Q3 		$2K Hold
250
– – ﹤0.01% 398
2019
Q2 		$3K Hold
250
– – ﹤0.01% 390
2019
Q1 		$4K Sell
250
-625
-71% -$10.4K ﹤0.01% 383
2018
Q4 		$15K Sell
875
-1,275
-59% -$21.7K 0.01% 282
2018
Q3 		$32K Sell
2,150
-200
-9% -$3.1K 0.03% 244
2018
Q2 		$37K Hold
2,350
– – 0.03% 238
2018
Q1 		$33K Sell
2,350
-3,050
-56% -$45.1K 0.03% 238
2017
Q4 		$76K Sell
5,400
-375
-6% -$5.49K 0.06% 189
2017
Q3 		$83K Sell
5,775
-775
-12% -$11.1K 0.07% 176
2017
Q2 		$103K Buy
6,550
+750
+13% +$10.8K 0.09% 168
2017
Q1 		$80K Buy
5,800
+1,125
+24% +$15.7K 0.07% 179
2016
Q4 		$83 Buy
+4,675
New +$82.1K 0.07% 172

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Pflug Koory's VIVO Position: Q4 2019 in Review

Pflug Koory sold out of Meridian Bioscience Inc (VIVO) in Q4 2019, closing a stake of 250 shares — an estimated $2K sold.

Pflug Koory first reported a position in VIVO in Q4 2016 and held it in 12 quarters. The position peaked at $103K in Q2 2017. 170 funds tracked by Wall St. Rank hold VIVO as of Q4 2019.

  • Pflug Koory reported no remaining Meridian Bioscience Inc position as of Q4 2019 after selling out during the quarter.
  • Pflug Koory sold 250 Meridian Bioscience Inc shares in Q4 2019, an estimated $2K.
  • Pflug Koory first reported a position in Meridian Bioscience Inc in Q4 2016 and held it in 12 quarters.
  • Pflug Koory's Meridian Bioscience Inc position peaked at $103K in Q2 2017.
  • 170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2019.

Based on Pflug Koory's 13F filing for Q4 2019, filed 14 Jan 2020.